dc.contributor.author | Abrahamsen, Greger | |
dc.contributor.author | Fan, Yongjun | |
dc.contributor.author | Matigian, Nicholas | |
dc.contributor.author | Wali, Gautam | |
dc.contributor.author | Bellette, Bernadette | |
dc.contributor.author | Sutharsan, Ratneswary | |
dc.contributor.author | Raju, Jyothy | |
dc.contributor.author | Wood, Stephen A | |
dc.contributor.author | Veivers, David | |
dc.contributor.author | Sue, Carolyn M | |
dc.contributor.author | Mackay-Sim, Alan | |
dc.date.accessioned | 2018-01-11T04:18:12Z | |
dc.date.available | 2018-01-11T04:18:12Z | |
dc.date.issued | 2013 | |
dc.date.modified | 2014-01-22T23:06:38Z | |
dc.identifier.issn | 1754-8403 | |
dc.identifier.doi | 10.1242/dmm.010884 | |
dc.identifier.uri | http://hdl.handle.net/10072/55945 | |
dc.description.abstract | Hereditary spastic paraplegia (HSP) leads to progressive gait disturbances with lower limb muscle weakness and spasticity. Mutations in SPAST are a major cause of adult-onset, autosomal-dominant HSP. Spastin, the protein encoded by SPAST, is a microtubule-severing protein that is enriched in the distal axon of corticospinal motor neurons, which degenerate in HSP patients. Animal and cell models have identified functions of spastin and mutated spastin but these models lack the gene dosage, mutation variability and genetic background that characterize patients with the disease. In this study, this genetic variability is encompassed by comparing neural progenitor cells derived from biopsies of the olfactory mucosa from healthy controls with similar cells from HSP patients with SPAST mutations, in order to identify cell functions altered in HSP. Patient-derived cells were similar to control-derived cells in proliferation and multiple metabolic functions but had major dysregulation of gene expression, with 57% of all mRNA transcripts affected, including many associated with microtubule dynamics. Compared to control cells, patient-derived cells had 50% spastin, 50% acetylated a-tubulin and 150% stathmin, a microtubule-destabilizing enzyme. Patient-derived cells were smaller than control cells. They had altered intracellular distributions of peroxisomes and mitochondria and they had slower moving peroxisomes. These results suggest that patient-derived cells might compensate for reduced spastin, but their increased stathmin expression reduced stabilized microtubules and altered organelle trafficking. Sub-nanomolar concentrations of the microtubule-binding drugs, paclitaxel and vinblastine, increased acetylated a-tubulin levels in patient cells to control levels, indicating the utility of this cell model for screening other candidate compounds for drug therapies. | |
dc.description.peerreviewed | Yes | |
dc.description.publicationstatus | Yes | |
dc.language | English | |
dc.language.iso | eng | |
dc.publisher | The Company of Biologists | |
dc.publisher.place | United Kingdom | |
dc.relation.ispartofstudentpublication | N | |
dc.relation.ispartofpagefrom | 489 | |
dc.relation.ispartofpageto | 502 | |
dc.relation.ispartofissue | 2 | |
dc.relation.ispartofjournal | Disease Models & Mechanisms | |
dc.relation.ispartofvolume | 6 | |
dc.rights.retention | Y | |
dc.subject.fieldofresearch | Biological sciences | |
dc.subject.fieldofresearch | Biomedical and clinical sciences | |
dc.subject.fieldofresearch | Neurosciences not elsewhere classified | |
dc.subject.fieldofresearchcode | 31 | |
dc.subject.fieldofresearchcode | 32 | |
dc.subject.fieldofresearchcode | 320999 | |
dc.title | A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations | |
dc.type | Journal article | |
dc.type.description | C1 - Articles | |
dc.type.code | C - Journal Articles | |
dcterms.license | http://creativecommons.org/licenses/by-nc-sa/3.0 | |
dc.description.version | Version of Record (VoR) | |
gro.faculty | Griffith Sciences, Griffith Institute for Drug Discovery | |
gro.rights.copyright | © 2013. Published by The Company of Biologists Ltd
This is an Open Access article distributed under the terms of the Creative Commons Attribution
Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0), which
permits unrestricted non-commercial use, distribution and reproduction in any medium provided
that the original work is properly cited and all further distributions of the work or adaptation are
subject to the same Creative Commons License terms. | |
gro.date.issued | 2013 | |
gro.hasfulltext | Full Text | |
gro.griffith.author | Mackay-Sim, Alan | |